The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.

The OUTPOST study (OUTcomes POST COVID) aims to track 1,500 Australians aged 12 and over who are currently experiencing flu-like symptoms. Participants will be monitored from the onset of their ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.

CAPE TOWN - The National Institute of Communicable Diseases (NICD) confirmed that flu season started on 24 March with ...

The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...

An Auckland high school closed early today after sickness left it unable to staff all classes, and as a top GP warns that the ...

The World Health Organization is monitoring a new mutation of the virus that’s already caused a surge in Asia.